scholarly article | Q13442814 |
P2093 | author name string | Marisa Dolhnikoff | |
Sheila Aparecida Coelho Siqueira | |||
Fabiola Del Carlo Bernardi | |||
Teresa Takagaki | |||
Marcela Del Carlo Bernardi | |||
P2860 | cites work | Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naive patients with advanced-stage non-small-cell lung cancer | Q29620301 |
United States lung carcinoma incidence trends: declining for most histologic types among males, increasing among females | Q38506876 | ||
The impact of immunohistochemistry on the classification of lung tumors. | Q38822314 | ||
Desmocollin-3: a new marker of squamous differentiation in undifferentiated large-cell carcinoma of the lung | Q44398817 | ||
p40 & thyroid transcription factor-1 immunohistochemistry: A useful panel to characterize non-small cell lung carcinoma-not otherwise specified (NSCLC-NOS) category | Q47136556 | ||
Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies. | Q51334457 | ||
Immunohistochemical algorithm for differentiation of lung adenocarcinoma and squamous cell carcinoma based on large series of whole-tissue sections with validation in small specimens. | Q51563657 | ||
Optimal immunohistochemical markers for distinguishing lung adenocarcinomas from squamous cell carcinomas in small tumor samples. | Q51630971 | ||
Various Antibody Clones of Napsin A, Thyroid Transcription Factor 1, and p40 and Comparisons With Cytokeratin 5 and p63 in Histopathologic Diagnostics of Non-Small Cell Lung Carcinoma. | Q52844020 | ||
Challenging Lung Carcinoma with Coexistent ΔNp63/p40 and Thyroid Transcription Factor-1 Labeling Within the Same Individual Tumor Cells. | Q52914937 | ||
Accuracy of classifying poorly differentiated non-small cell lung carcinoma biopsies with commonly used lung carcinoma markers. | Q53582166 | ||
Refining the diagnosis and EGFR status of non-small cell lung carcinoma in biopsy and cytologic material, using a panel of mucin staining, TTF-1, cytokeratin 5/6, and P63, and EGFR mutation analysis. | Q54446617 | ||
ΔNp63 (p40) and Thyroid Transcription Factor-1 Immunoreactivity on Small Biopsies or Cellblocks for Typing Non-small Cell Lung Cancer: A Novel Two-Hit, Sparing-Material Approach | Q56779202 | ||
Targeted therapy for lung cancer | Q84895468 | ||
Lung cancer histologic and immunohistochemical heterogeneity in the era of molecular therapies: analysis of 172 consecutive surgically resected, entirely sampled pulmonary carcinomas | Q87125545 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | immunohistochemistry | Q899285 |
P304 | page(s) | e361 | |
P577 | publication date | 2018-10-29 | |
P1433 | published in | Clinics | Q26841864 |
P1476 | title | Lung cancer biopsy: Can diagnosis be changed after immunohistochemistry when the H&E-Based morphology corresponds to a specific tumor subtype? | |
P478 | volume | 73 |
Search more.